Non-bacterial Cystitis With Increased Expression of Programmed Cell Death Ligand 1 in the Urothelium: An Unusual Immune-Related Adverse Event After Atezolizumab Administration for Metastatic Breast Cancer

We report a case of non-bacterial cystitis that occurred after administration of atezolizumab, an antibody against programmed cell death ligand 1 (PD-L1). This cystitis was considered an immune-related adverse event (irAE). A 67-year-old woman with advanced breast cancer (cT4bN1M1, cStage IV) was tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Obayashi, Aiko, Hamada-Nishimoto, Mai, Fujimoto, Yuri, Yoshimoto, Yukiko, Takahara, Sachiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Pathology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9246443/
https://www.ncbi.nlm.nih.gov/pubmed/35800819
http://dx.doi.org/10.7759/cureus.25486

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9246443/
https://www.ncbi.nlm.nih.gov/pubmed/35800819
http://dx.doi.org/10.7759/cureus.25486

Ejemplares similares